Related Experiment Video

Updated: Jun 3, 2026

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
06:59

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

Published on: May 12, 2023

Pazopanib for the treatment of renal cancer

Mhd Yaser Al-Marrawi1, Brian Rini

  • 1Cleveland Clinic Taussig Cancer Institute, R35, 9500 Euclid Avenue, Cleveland, OH 44195, USA. almarrm@ccf.org [corrected]

Expert Opinion on Pharmacotherapy
|April 8, 2011
PubMed
Abstract

Insights

Pazopanib is a targeted therapy for advanced renal cell carcinoma (RCC) that inhibits key growth factor receptors involved in cancer progression. Clinical data confirm pazopanib as a highly effective treatment option for metastatic RCC.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Recent advances in advanced renal cell carcinoma (RCC) care highlight the role of angiogenesis signaling pathways.
  • Pazopanib, a novel tyrosine kinase inhibitor, targets VEGFRs, PDGFRs, and c-kit, offering a distinct profile among VEGF pathway inhibitors.

Purpose of the Study:

  • To review the scientific rationale behind pazopanib's development for advanced RCC.
  • To discuss preclinical and clinical trials supporting pazopanib's approval.
  • To propose a treatment algorithm for advanced RCC based on current evidence.

Main Methods:

  • Review of scientific literature and clinical trial data.
  • Analysis of pazopanib's preclinical and clinical efficacy and safety.
  • Inclusion of recent data from major oncology conferences.

Main Results:

  • Pazopanib targets multiple receptor tyrosine kinases crucial for tumor growth and angiogenesis.
  • Clinical trials demonstrate pazopanib's efficacy in patients with advanced RCC.
  • Pazopanib has a unique pharmacokinetic and toxicity profile compared to other VEGF inhibitors.

Conclusions:

  • The treatment landscape for metastatic RCC has significantly evolved with the introduction of novel targeted agents.
  • Pazopanib is one of six recently approved agents for metastatic RCC.
  • Clinical evidence positions pazopanib as a leading targeted therapy for advanced RCC.

More Related Videos

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...